Longeveron Management
Management criteria checks 1/4
Longeveron's CEO is Mohamed Wa'el Hashad, appointed in Mar 2023, has a tenure of 1.17 years. total yearly compensation is $1.58M, comprised of 27.4% salary and 72.6% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth $35.51K. The average tenure of the management team and the board of directors is 1 years and 3.3 years respectively.
Key information
Mohamed Wa'el Hashad
Chief executive officer
US$1.6m
Total compensation
| CEO salary percentage | 27.4% |
| CEO tenure | 1.2yrs |
| CEO ownership | 0.3% |
| Management average tenure | less than a year |
| Board average tenure | 3.3yrs |
Recent management updates
Recent updates
Will Longeveron (NASDAQ:LGVN) Spend Its Cash Wisely?
Nov 17
Longeveron Inc.: A New Approach To Treat Alzheimer's
Oct 09Longeveron spikes after FDA’s Fast Track Designation for lead candidate
Aug 31Is Longeveron (NASDAQ:LGVN) In A Good Position To Invest In Growth?
Jul 15Longeveron rises ~20%, co to present Alzheimer's trial abstract at leading conference
Jul 07Longeveron: Small-Cap Biotech Targeting Large Alzheimer's Market
May 06Companies Like Longeveron (NASDAQ:LGVN) Are In A Position To Invest In Growth
Apr 03Longeveron: Speculative Biotech Worth A Look On Rare Disease, Aging, And Alzheimer's Focuses
Feb 15Longeveron: Spooky Social-Media Generated Spike Signifies Nothing
Nov 29Is Longeveron (NASDAQ:LGVN) In A Good Position To Deliver On Growth Plans?
Nov 20CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | US$2m | US$431k | -US$22m |
Compensation vs Market: Mohamed Wa'el's total compensation ($USD1.58M) is above average for companies of similar size in the US market ($USD674.55K).
Compensation vs Earnings: Insufficient data to compare Mohamed Wa'el's compensation with company performance.
CEO
Mohamed Wa'el Hashad (61 yo)
1.2yrs
Tenure
US$1,576,559
Compensation
Mr. Mohamed Wa'el Ahmed Hashad, M.B.A. has been Chief Executive Officer at Longeveron Inc. since March 01, 2023 and also has been its Director since June 09, 2023. Mr. Hashad has been Independent Director...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.3yrs | US$87.13k | 8.87% $ 1.2m | |
| CEO & Director | 1.2yrs | US$1.58m | 0.27% $ 35.5k | |
| Executive VP & CFO | less than a year | US$380.78k | 0.023% $ 3.0k | |
| International Executive Director | no data | US$554.06k | 0.17% $ 22.5k | |
| Senior Vice President of Strategic Collaborations & Scientific Affairs | 3yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | 0.018% $ 2.4k | |
| VP & Corporate Controller | less than a year | no data | no data |
1.0yrs
Average Tenure
55yo
Average Age
Experienced Management: LGVN's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 10.3yrs | US$87.13k | 8.87% $ 1.2m | |
| CEO & Director | less than a year | US$1.58m | 0.27% $ 35.5k | |
| Independent Director | 3.3yrs | US$63.63k | 0.0069% $ 905.4 | |
| Independent Director | 3.3yrs | US$70.63k | 0.014% $ 1.8k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | less than a year | US$63.17k | 0.017% $ 2.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 8.7yrs | US$52.13k | 4.23% $ 550.8k | |
| Director | 4.2yrs | US$55.63k | 2.9% $ 377.4k | |
| Independent Director | 2.9yrs | US$62.63k | 0.0069% $ 905.4 |
3.3yrs
Average Tenure
60.5yo
Average Age
Experienced Board: LGVN's board of directors are considered experienced (3.3 years average tenure).